# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!



Black Lung Disease
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-9 of 9 results.
The Experience of Patients and Family Caregivers in Managing Pneumoconiosis in the Family Context
Status: Recruiting
Last Changed: Jul 17, 2019
First Received: Jul 17, 2019
Disease(s): Pneumoconiosis
Intervention(s): No intervention
Locations: Pneumoconiosis Compensation Fund Board, Hong Kong, Hong Kong
Examination of Pirfenidone (Esbriet®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis
Status: Recruiting
Last Changed: Sep 04, 2020
First Received: Jul 08, 2020
Disease(s): Coal Workers' Pneumoconiosis (Complicated)
Intervention(s): Pirfenidone
Locations: Pulmonary Research of Abingdon, LLC, Abingdon, Virginia, United States
The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial
Status: Not yet recruiting
Last Changed: Nov 13, 2019
First Received: Nov 13, 2019
Disease(s): Pneumoconiosis Coal, Asbestosis, Silicosis
Intervention(s): Nintedanib 150 MG [Ofev]
Locations: Holdsworth House Medical Practice, Sydney, New South Wales, Australia
Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma
Status: Recruiting
Last Changed: May 22, 2020
First Received: Dec 19, 2019
Disease(s): Silicosis, Pneumoconiosis; Silica
Intervention(s): Tuberculosis test, Chest X-ray, Pulmonary Function Test
Locations: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD)
Status: Recruiting
Last Changed: Sep 09, 2020
First Received: Nov 13, 2015
Disease(s): Chronic Beryllium Disease
Intervention(s): Nothing
Locations: National Jewish Health, Denver, Colorado, United States
Effects of Silica and Asbestos Fibres on the Efferocytosis Capacities of Macrophages
Status: Not yet recruiting
Last Changed: Jul 16, 2020
First Received: Jul 16, 2020
Disease(s): History of Exposure to Silica or Asbestosis, Positive Testing for ANA as a Marker of Systemic Autoimmune Diseases
Intervention(s): Blood collection, Blood sample, Blood sample
Locations: CHU de Rennes, Rennes, France
Short Course Rifapentine and Isoniazid for the Preventive Treatment of Tuberculosis(SCRIPT-TB)
Status: Recruiting
Last Changed: Apr 05, 2019
First Received: Apr 03, 2019
Disease(s): Silicosis Tuberculosis
Intervention(s): Isoniazid;Rifapentine
Locations: Wenling No.1 People's Hospital, Zhejiang, Taizhou, Zhejiang, China
Audiovestibular Function in Infratentorial Superficial Siderosis
Status: Recruiting
Last Changed: Feb 20, 2020
First Received: Dec 16, 2019
Disease(s): Siderosis, Neurological Disorder, Rare Diseases, Age Related Hearing Loss, Presbycusis
Intervention(s): Hearing assessment, Vestibular/balance assessment, Quality of life assessment, Olfactory (smell) function testing, DNA bio-banking
Locations: UCL Ear Institute, London, United Kingdom
University College London Hospitals NHS Foundation Trust, London, United Kingdom
Cortical Superficial Siderosis and Risk of Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy.
Status: Recruiting
Last Changed: Aug 20, 2019
First Received: Mar 14, 2018
Disease(s): Cerebral Amyloid Angiopathy
Intervention(s): neurological, neuropsychological and MRI evaluation
Locations: Pellegrin Hospital, Bordeaux, France
Gui de Chauliac Hospital, Montpellier, France
Lariboisière Hospital, Paris, France
CHU Purpan. Hôpital Pierre-Paul Riquet, Toulouse cedex 9, France